201 related articles for article (PubMed ID: 17906459)
1. Molecular targeted therapies and chemotherapy in malignant gliomas.
Brandsma D; van den Bent MJ
Curr Opin Oncol; 2007 Nov; 19(6):598-605. PubMed ID: 17906459
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in the use of chemotherapy in brain tumours.
van den Bent MJ; Hegi ME; Stupp R
Eur J Cancer; 2006 Mar; 42(5):582-8. PubMed ID: 16427778
[TBL] [Abstract][Full Text] [Related]
3. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
[TBL] [Abstract][Full Text] [Related]
5. Low-grade gliomas.
Schiff D
Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):345-54. PubMed ID: 25837900
[TBL] [Abstract][Full Text] [Related]
6. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
Stupp R; Hegi ME; van den Bent MJ; Mason WP; Weller M; Mirimanoff RO; Cairncross JG; ;
Oncologist; 2006 Feb; 11(2):165-80. PubMed ID: 16476837
[TBL] [Abstract][Full Text] [Related]
7. Neuro-oncology: the growing role of chemotherapy in glioma.
Carpentier AF
Lancet Neurol; 2005 Jan; 4(1):4-5. PubMed ID: 15620846
[No Abstract] [Full Text] [Related]
8. [Management of gliomas].
Lévy S; Chapet S; Mazeron JJ
Cancer Radiother; 2014 Oct; 18(5-6):461-7. PubMed ID: 25201633
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances in chemotherapy for malignant gliomas].
Yoshino A; Katayama Y
No Shinkei Geka; 2008 Feb; 36(2):173-83. PubMed ID: 18265701
[No Abstract] [Full Text] [Related]
10. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
11. New chemotherapy options for the treatment of malignant gliomas.
Burton E; Prados M
Curr Opin Oncol; 1999 May; 11(3):157-61. PubMed ID: 10328588
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
van den Bent MJ; Looijenga LH; Langenberg K; Dinjens W; Graveland W; Uytdewilligen L; Sillevis Smitt PA; Jenkins RB; Kros JM
Cancer; 2003 Mar; 97(5):1276-84. PubMed ID: 12599236
[TBL] [Abstract][Full Text] [Related]
13. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.
Kouwenhoven MC; Kros JM; French PJ; Biemond-ter Stege EM; Graveland WJ; Taphoorn MJ; Brandes AA; van den Bent MJ
Eur J Cancer; 2006 Oct; 42(15):2499-503. PubMed ID: 16914310
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of Oligodendrogliomas.
Drappatz J; Lieberman F
Prog Neurol Surg; 2018; 31():152-161. PubMed ID: 29393183
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy in glioma.
Taal W; Bromberg JE; van den Bent MJ
CNS Oncol; 2015; 4(3):179-92. PubMed ID: 25906059
[TBL] [Abstract][Full Text] [Related]
16. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
Siker ML; Chakravarti A; Mehta MP
Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
[TBL] [Abstract][Full Text] [Related]
18. Current management of low-grade gliomas.
Hottinger AF; Hegi ME; Baumert BG
Curr Opin Neurol; 2016 Dec; 29(6):782-788. PubMed ID: 27676279
[TBL] [Abstract][Full Text] [Related]
19. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.
Walker C; Haylock B; Husband D; Joyce KA; Fildes D; Jenkinson MD; Smith T; Broome J; du Plessis DG; Warnke PC
Neurology; 2006 Jun; 66(11):1661-7. PubMed ID: 16769937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
